LBX Pharmacy Chain Joint Stock Company (SHA:603883)
14.47
-0.13 (-0.89%)
Oct 29, 2026, 1:05 PM CST
SHA:603883 Revenue
In the year 2025, LBX Pharmacy Chain Joint Stock Company had annual revenue of 22.24B CNY, down -0.54%. That makes LBX Pharmacy Chain Joint Stock Company the 3,478th largest company in the world by revenue and 426th in China.
Revenue
22.24B
Revenue Growth
-0.54%
P/S Ratio
0.49
Revenue / Employee
618.47K
Employees
36,892
Market Cap
10.98B
Revenue by Segment
- Pharmaceutical Retail 19.11B 60.0%
- Wholesale Division 12.31B 38.6%
- Others 442.02M 1.4%
Fiscal year ended Dec 31, 2025 See the full SHA:603883 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.24B | -120.99M | -0.54% |
| Dec 31, 2024 | 22.36B | -79.88M | -0.36% |
| Dec 31, 2023 | 22.44B | 2.26B | 11.21% |
| Dec 31, 2022 | 20.18B | 4.48B | 28.54% |
| Dec 31, 2021 | 15.70B | 1.73B | 12.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 27.97B |
| Yifeng Pharmacy Chain | 24.84B |
| Luyan Pharma | 21.57B |
| Cachet Pharmaceutical | 18.10B |
| Yixintang Pharmaceutical Group | 16.89B |
| ShuYu Civilian Pharmacy Corp. | 10.76B |
| Jianzhijia Pharmaceutical Chain Group | 8.65B |
| Anhui Huaren Health Pharmaceutical | 5.91B |